Navigation Links
Gold Standard/Elsevier offers timely, reliable drug pricing data, including average wholesale price
Date:5/18/2010

TAMPA, FL 18 May, 2010 Gold Standard/Elsevier, publisher of drug information databases and decision support solutions, has announced its commitment to continue publishing transparent drug pricing information, including average wholesale price (AWP) and all other current and future pricing benchmarks. This announcement comes amidst statements by other drug database suppliers indicating they will discontinue publishing AWP in 2011.

"Gold Standard reports all drug pricing standards utilized and required within the industry, and we intend to continue doing so," stated Kay Morgan, Senior Vice President, Drug Product and Industry Standards Research and Compliance for Gold Standard/Elsevier. "We understand the frustrations felt by those who rely on AWP and expect stability and dependability from their drug databases. We look forward to providing a reliable and flexible resource for pricing industry-wide, including AWP and any new benchmarks, through our Alchemy drug database and ProspectoRx pricing analysis tool."

Gold Standard/Elsevier supports transparent price benchmarks for payers (health plans, patients, government agencies and employers), pharmacies and other providers for prescription drugs. The company publishes reported and calculated drug prices that are clearly distinguished within the database, and adheres to strict internal policies for populating reported versus calculated pricing fields. Drug company reported prices of AWP, WAC (wholesale acquisition cost), CMS FUL (Federal Upper Limit), and Direct Price are included in Gold Standard's database. The company's calculated price types include: Calculated AWP 1.25 (25% mark-up), Calculated AWP 1.20 (20% mark-up), and Calculated CMS FUL.

Gold Standard/Elsevier provides comprehensive drug pricing data via its Alchemy integrated drug database and ProspectoRx web-based drug pricing and analysis tool. Both sources offer the most frequent and accurate updates in the industry. Following review and confirmation by editorial professionals, price changes are published "live" throughout the day as they are reported by drug companies. The company's unique Price Change Indicator tracks pricing change catalysts consistently, reporting on whether the source came from the drug company's reports, billing unit changes or errors.

"Customers of Gold Standard/Elsevier benefit from receiving new drug product and pricing data sooner due to our superior data modeling, which affords us the quickest and most efficient turnaround for price changes and industry updates," continued Morgan.

Alchemy is an integrated drug database and drug decision support engine that fulfills the evolving medication management needs of today's complex healthcare systems and applications. Alchemy delivers the most current and accurate drug data and decision support tools seamlessly and cost-effectively, taking users far beyond the capabilities of other drug databases.


'/>"/>

Contact: Tom Reller
T.Reller@Elsevier.com
212-462-1912
Elsevier
Source:Eurekalert

Related biology news :

1. Paper offers new insights into the genomics of speciation
2. NASA, Purdue study offers recipe for global warming-free industrial materials
3. Sinbad Sweets(TM) Offers Select New Desserts at 50% Off Regular Price
4. Take Advantage of Lancasters Offers at This Years Autojumble
5. Vicious circle offers new acute leukemia treatment target
6. Nations largest organization of ecologists offers expert database
7. Fertility industry offers big money to recruit desirable egg donors at top universities
8. DNA nanotechnology breakthrough offers promising applications in medicine
9. New microscopy technique offers close-up, real-time view of cellular phenomena
10. Society of Interventional Radiology Press offers new edition of patient care resource
11. The sea squirt offers hope for Alzheimers sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016 Aware, Inc. (NASDAQ: AWRE ), a leading ... its fourth quarter and year ended December 31, 2015.  ... quarter of 2015 was $6.9 million, an increase of 61% compared ... in the fourth quarter of 2015 was $2.6 million compared to ... --> --> Higher revenue and operating income ...
(Date:2/8/2016)... PRAGUE, Czech Republic , February 8, 2016 ... first EU-regulated global payment platform which presents innovation ... Voice Biometrics Authentication feature called VoiceKey. --> ... payment platform which presents innovation for clients, comfort ... feature called VoiceKey. --> Worldcore ...
(Date:2/4/2016)... , Feb. 4, 2016 The ... apparently one of the most popular hubs of ... MetaHIT and other huge studies of human microbiota, ... past few years, the microbiome space has literally ... biomedical research. This report focuses on biomedical ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... 11, 2016 , ... Global Stem Cells Group, ... Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular ... , The new GSCG clinic is headed by four prominent Ecuadorian physicians, ...
(Date:2/10/2016)... , Feb.10, 2016 ASAE is introducing a ... Management Companies (AMC) the option of joining or renewing ... fee determined by staff size, every employee in any ... ASAE and reap all available member benefits.   ... new organizational membership options will allow organizations of any ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a ... promotion of two long-standing principal investigators (PI) to the roles of Chief Medical ... Development. , Dr. Laurence Chu, a Benchmark Research PI in the Austin office, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... on Microsoft Azure. On Azure, Arvados provides capabilities for managing and processing genomic ... for Microsoft Azure from major institutions collecting and analyzing genomic data,” said Adam ...
Breaking Biology Technology: